Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
  • Overview
  • Recognition

About Patrick

J. Patrick Finn III, Ph.D., serves as managing principal of Fish & Richardson’s Munich office while also maintaining an active IP practice in the Twin Cities. His practice emphasizes patent preparation and prosecution, strategic portfolio management, patentability and freedom to operate searching and analysis, inter partes review (IPR) proceedings, opinions, due diligence investigations, licensing and counseling in the medical biotechnology, agricultural biotechnology, diagnostic, pharmaceutical, and medical science fields.

His projects have involved subject matter such as novel nucleic acid constructs, engineered antibodies, gene therapies, vaccines, antisense therapeutics, RNA interference therapeutics, genome editing techniques, stem cells, transgenic plants, transgenic animals, proteomics, transcription factors, regulator elements, cell culture techniques, high-throughput screening assays, diagnostic assays and agents, microarrays, medical devices, and potential treatments for diseases such as cardiovascular disease, cancer, allergy, arthritis, diabetes, and Alzheimer’s disease. Dr. Finn works with universities, pharmaceutical companies, medical device companies, investment firms, and emerging and established companies in the field of biotechnology.

His licensing experience includes university/industry collaborations, patent out-licensing and in-licensing programs, and joint ventures.

As a Ph.D. candidate at the University of California, Los Angeles, Dr. Finn acquired extensive experience in molecular and cellular biology. In particular, he regularly performed molecular cloning and protein purification techniques as well as analytical activity assays such as transport assays designed to measure neurotransmitter transport into vesicles. One focus of Dr. Finn’s graduate work involved a structural and functional characterization of vesicular transport proteins such as the vesicular monoamine transporters (VMATs).

Recognized in “The World’s Leading Patent Practitioners” by IAM Patent 1000 (2019-2021).

Recognized as “Minnesota 500 – Most Powerful Business Leaders in Minnesota” (2018-2019).

Focus Areas
Education

J.D. cum laude, William Mitchell College of Law (2002)


Ph.D., Microbiology and Immunology, University of California, Los Angeles (1997)


B.S. with distinction, Biology, Pennsylvania State University (1991)

Admissions
  • U.S. Patent and Trademark Office 1999
  • Minnesota 2002

What's trending with Patrick

Filter by
News
July 7, 2021
Fish & Richardson Receives Top Rankings in 2021 Edition of IAM Patent 1000: The World’s Leading Patent Professionals
Recognition
News
News
January 7, 2021
Fish & Richardson Receives 2020 “Attorney of the Year” Group Award from Minnesota Lawyer
Press Release
Recognition
News
News
December 3, 2020
Patrick Finn Interviewed By Minnesota Lawyer, "Breaking the Ice: IP ‘family’ grows with virus-related patent"
Media Mention
News
News
August 12, 2020
Fish & Richardson Receives Top “Gold” Ranking from IAM Patent 1000 for National Litigation Practice; National Rankings in the Plaintiff Firm and Prosecution Firm Categories
Press Release
Recognition
News
News
June 20, 2019
Fish & Richardson Receives Top “Gold” Ranking from IAM Patent 1000 for National Patent Litigation Practice
Press Release
Recognition
News
Event
July 9th, 2018 | 8:00 am CDT
Association of University Technology Managers 2018 Central Region Meeting
Sponsorship
News
June 14, 2018
Fish Receives Top “Gold” Ranking from IAM Patent 1000 for National Patent Litigation Practice
Press Release
News
News
September 27, 2017
Fish & Richardson Announces Mayo/Myriad Life Sciences Tracker
Press Release
News
News
July 24, 2017
Fish & Richardson Receives Top “Gold” Ranking from IAM Patent 1000 for National Patent Litigation Practice
Press Release
News
Event
September 30th, 2013
How Do Patents Help or Hinder Personalized Medicine?
Speaking Engagement
load more topics
TOP